期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Blood hemoperfusion with resin adsorption combined continuous veno-venous hemofiltration for patients with multiple organ dysfunction syndrome 被引量:8
1
作者 Lu-yi Liu Yong-jian Zhu +3 位作者 Xiao-li Li Ya-feng Liang Zuo-peng Liang Yong-hong Xia 《World Journal of Emergency Medicine》 CAS 2012年第1期44-48,共5页
BACKGROUND:Blood hemoperfusion with resin adsorption can clean larger molecules that exceed the molecular weight cutoff of combined continuous veno-venous hemofiltration(CWH).Hence blood hemoperfusion with resin adsor... BACKGROUND:Blood hemoperfusion with resin adsorption can clean larger molecules that exceed the molecular weight cutoff of combined continuous veno-venous hemofiltration(CWH).Hence blood hemoperfusion with resin adsorption combined CWH(HP+CWH) has higher ability of mediator clearance,and can improve clinical outcomes in theory.This study aimed to investigate the effect of blood hemoperfusion with resin adsorption combined continuous veno-venous hemofiltration(HP+CWH) on plasm cytokines like TNF-α,IL-1β,IL-6,cellular immunity and prognosis in patients with multiple organ dysfunction syndrome(MODS).METHODS:This was a prospective,randomized clinical trial.A total of 30 patients who had been diagnosed with MODS were enrolled in this study.Patients were randomly allocated to routine treatment+HP+CWH group(treatment group) and routine treatment+only CWH group(control group).In the treatment group,patients received blood hemoperfusion with resin adsorption for 2hours,and then received CWH for 10 hours every day.In the control group,patients received CWH for 12 hours only every day.The patients in the two groups received blood purification therapy for three days.The plasma of patients in the treatment group was obtained at 0,2,12,24,26,36,48,50,60 hours,5th day,7th day and 10 th day,respectively.The plasma of patients in the control group was obtained at 0,12,24,36,48,60 hours,5th day,7th day and 10 th day,respectively.APACHE Ⅱscore,T-lymphocytes subpopulations,blood lactate acid concentration,heart rate,breathing rate,and oxygenation index were observed.RESULTS:Plasma cytokines like TNF-α,IL-1β,IL-6 decreased markedly after HP(P<0.01);T-lymphocytes subpopulations CD3+,CD4+,CD8+,CD4+/CD8+ increased after HP+CWH or only CWH.The plasma concentrations of TNF-α,IL-1β and IL-6 in the two groups were not markedly different at 12,36,and 50 hours.But on the 5th day,the plasma concentrations of TNF-α,IL-1β and IL-6 in the treatment group were lower than those in the control group(P<0.05).On the 28 th day,5patients died in the treatment group,and 6 patients in the control group.CONCLUSIONS:Both HP+CWH and CWH can clean plasma cytokines like TNF-α,IL-1β,and IL-6,and improve cellular immunity and clinical symptoms and signs of patients.Compared with only CWH,the plasma concentrations of TNF-α,IL-1β and IL-6 were lower on the 5th day,and patients have an increased survival rate on the 28 day in the HP+CWH group. 展开更多
关键词 Hemoperfusion with resin adsorption continuous veno-venous hemofiltration Multiple organ dysfunction syndrome CYTOKINES
下载PDF
CRRT联合血液吸附对重症MODS患者血管内皮细胞的损伤的影响 被引量:3
2
作者 胡海棠 窦献蕊 +5 位作者 张炜 刘燕芬 卢瑞兴 廖健荘 谢文帧 区艳秋 《国际医药卫生导报》 2010年第24期2972-2975,共4页
目的 探讨利用CRRT及CRRT联合血液吸附方法对重症MODS患者血清血管内皮细胞生长因子-1(VCAM-1)的影响.方法 收集重症MODS患者43例,CRRT治疗组28例,联合治疗组15例,分别给予CRRT及CRRT联合血液吸附治疗.收集治疗前后血清,用ELISA的方... 目的 探讨利用CRRT及CRRT联合血液吸附方法对重症MODS患者血清血管内皮细胞生长因子-1(VCAM-1)的影响.方法 收集重症MODS患者43例,CRRT治疗组28例,联合治疗组15例,分别给予CRRT及CRRT联合血液吸附治疗.收集治疗前后血清,用ELISA的方法检测患者血清VCAM-1水平,并对患者行APACHEⅡ评分.结果 CRRT组治疗前sVCAM-1(1865.96±726.77)ng/ml,治疗后sVCAM-1(1783.55±868.92)ng/ml;联合组治疗前sVCAM-1(1958.27±932.14)ng/ml,治疗后sVCAM-1(1259.67±687.35)ng/ml,与治疗前比较差异有极显著性(P〈0.01).结论 sVCAM-1可作为评价重症MODS患者严重程度的指标且CRRT联合血液吸附明显改善MODS患者内皮细胞功能. 展开更多
关键词 多脏器功能不全综合征 内皮细胞 炎症因子 血液吸附 连续性血液滤过
下载PDF
血液灌流联合连续性肾脏替代治疗技术治疗重症胰腺炎 被引量:2
3
作者 张正荣 龚俞函 +4 位作者 杨红 龙艳 龙必芳 胡萍 廖兰仙 《透析与人工器官》 2009年第4期17-19,共3页
目的观察血液灌流联合连续性肾脏替代治疗(continuous renal replacement therapy,CRRT)技术治疗重症胰腺炎(severe acute pancreatitis,SAP)患者的临床疗效,并探讨其机制。方法将30例患者随机分成两组:联合治疗组15例采用CRRT+血液灌... 目的观察血液灌流联合连续性肾脏替代治疗(continuous renal replacement therapy,CRRT)技术治疗重症胰腺炎(severe acute pancreatitis,SAP)患者的临床疗效,并探讨其机制。方法将30例患者随机分成两组:联合治疗组15例采用CRRT+血液灌流治疗;对照组15例采用单纯CRRT治疗。比较两组治疗前后临床症状、APACHEⅡ评分改善、TNF-α及IL-6变化情况。结果两组治疗后,患者临床症状缓解,血清TNF-α及IL-6均降低,但联合治疗组明显优于对照组(P<0.05)。结论血液灌流联合CRRT治疗重症胰腺炎可有效调整炎症因子水平,提高患者的治疗效果。 展开更多
关键词 血液灌流 连续性静-静脉血液滤过(continuous veno-venous hemofiltration CVVH) 重症胰腺炎(severe acute pancreatitis SAP)
下载PDF
连续性和反复间断血液滤过治疗重症急性胰腺炎的临床价值 被引量:1
4
作者 聂晓冬 王昌松 +1 位作者 刘牧 赵平 《华西医学》 CAS 2009年第4期878-881,共4页
目的:研究早期连续性静脉-静脉血液滤过和反复间断静脉一静脉血滤治疗重症急性胰腺炎的临床价值。方法:45例SAP患者随机分为CVVH组(25例)和RIVVH组(20例)。比较2组患者的生命体征、生化指标、治疗前后的APACHEⅡ评分、死亡率、好转率。... 目的:研究早期连续性静脉-静脉血液滤过和反复间断静脉一静脉血滤治疗重症急性胰腺炎的临床价值。方法:45例SAP患者随机分为CVVH组(25例)和RIVVH组(20例)。比较2组患者的生命体征、生化指标、治疗前后的APACHEⅡ评分、死亡率、好转率。结果:CVVH组中3例死于MODS,死亡率为12%,RIVVH组死亡3例(15%),其差异有统计学意义(P<0.05);CVVH组好转率为80%(20/25),与RIVVH组的80%(16/20)一致。在治疗的早期阶段,对于改善生命体征,降低APACHEⅡ评分CVVH效果更显注,但随着治疗时间的延长,这种差异逐渐变小,在后期两组间不再存在疗效差异,最终疗效上没有明显的差异,而RIVVH组,在治疗费用和人员成本上具有优势。结论:早期RIVVH治疗SAP可以作为SAP重要的辅助治疗措施。 展开更多
关键词 重症急性胰腺炎 连续性静脉-静脉血液滤过 反复间断静脉一静脉血液滤过
原文传递
Severe crush syndrome complicated with acute pancreatitis: a case report and review of the literatures
5
作者 LIU Fang ZHANG Ling +6 位作者 FU Ping SU Bai-hai CHEN Xiao-lei LIU Ling CHEN Wei-xia TAO Ye HUANG Song-min 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第24期3103-3105,共3页
Earthquake is one of the most catastrophic natural disasters. As we know, crush syndrome is the secondmost frequent cause of mortality after the direct impact of trauma.1-3 It is a serious clinical case that develops ... Earthquake is one of the most catastrophic natural disasters. As we know, crush syndrome is the secondmost frequent cause of mortality after the direct impact of trauma.1-3 It is a serious clinical case that develops among casualties of earthquakes or other catastrophic events that may also result in a variety of ensuing uncommon complications. Cases of crush syndrome complicated with acute pancreatitis (AP) following the earthquakes are seldom reported. 展开更多
关键词 crush syndrome acute renal failure acute panereatitis continuous veno-venous hemofiltration
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部